Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of $231.28 billion. The enterprise value is $252.81 billion.
Important Dates
The next confirmed earnings date is Tuesday, October 29, 2024, before market open.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | Mar 7, 2024 |
Share Statistics
Novartis AG has 2.02 billion shares outstanding. The number of shares has decreased by -3.53% in one year.
| Shares Outstanding | 2.02B |
| Shares Change (YoY) | -3.53% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.93B |
Valuation Ratios
The trailing PE ratio is 14.30 and the forward PE ratio is 14.57.
| PE Ratio | 14.30 |
| Forward PE | 14.57 |
| PS Ratio | n/a |
| Forward PS | 4.53 |
| PB Ratio | n/a |
| P/FCF Ratio | 16.63 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.10, with an EV/FCF ratio of 18.17.
| EV / Earnings | 15.63 |
| EV / Sales | 5.17 |
| EV / EBITDA | 13.10 |
| EV / EBIT | 17.10 |
| EV / FCF | 18.17 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.69.
| Current Ratio | 0.93 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 1.48 |
| Debt / FCF | 2.08 |
| Interest Coverage | 16.31 |
Financial Efficiency
Return on equity (ROE) is 21.50% and return on invested capital (ROIC) is 12.22%.
| Return on Equity (ROE) | 21.50% |
| Return on Assets (ROA) | 8.86% |
| Return on Capital (ROIC) | 12.22% |
| Revenue Per Employee | $642,413 |
| Profits Per Employee | $212,669 |
| Employee Count | 76,057 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 1.71 |
Taxes
In the past 12 months, Novartis AG has paid $814.00 million in taxes.
| Income Tax | 814.00M |
| Effective Tax Rate | 7.47% |
Stock Price Statistics
The stock price has increased by +20.74% in the last 52 weeks. The beta is 0.50, so Novartis AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +20.74% |
| 50-Day Moving Average | 116.26 |
| 200-Day Moving Average | 106.33 |
| Relative Strength Index (RSI) | 42.44 |
| Average Volume (20 Days) | 889,031 |
Short Selling Information
| Short Interest | 5.70M |
| Short Previous Month | 5.70M |
| Short % of Shares Out | 0.28% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.21 |
Income Statement
In the last 12 months, Novartis AG had revenue of $48.86 billion and earned $16.18 billion in profits. Earnings per share was $7.84.
| Revenue | 48.86B |
| Gross Profit | 36.91B |
| Operating Income | 14.78B |
| Pretax Income | 16.99B |
| Net Income | 16.18B |
| EBITDA | 19.30B |
| EBIT | 14.78B |
| Earnings Per Share (EPS) | $7.84 |
Full Income StatementBalance Sheet
The company has $8.43 billion in cash and $28.99 billion in debt, giving a net cash position of -$20.56 billion or -$10.15 per share.
| Cash & Cash Equivalents | 8.43B |
| Total Debt | 28.99B |
| Net Cash | -20.56B |
| Net Cash Per Share | -$10.15 |
| Equity (Book Value) | 41.90B |
| Book Value Per Share | 20.61 |
| Working Capital | -1.92B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $15.07 billion and capital expenditures -$1.15 billion, giving a free cash flow of $13.91 billion.
| Operating Cash Flow | 15.07B |
| Capital Expenditures | -1.15B |
| Free Cash Flow | 13.91B |
| FCF Per Share | $6.87 |
Full Cash Flow StatementMargins
Gross margin is 75.55%, with operating and profit margins of 30.25% and 33.10%.
| Gross Margin | 75.55% |
| Operating Margin | 30.25% |
| Pretax Margin | 22.31% |
| Profit Margin | 33.10% |
| EBITDA Margin | 39.49% |
| EBIT Margin | 30.25% |
| FCF Margin | 29.25% |
Dividends & Yields
This stock pays an annual dividend of $3.78, which amounts to a dividend yield of 3.30%.
| Dividend Per Share | $3.78 |
| Dividend Yield | 3.30% |
| Dividend Growth (YoY) | 8.88% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 48.20% |
| Buyback Yield | 3.53% |
| Shareholder Yield | 6.83% |
| Earnings Yield | 6.99% |
| FCF Yield | 6.01% |
Dividend DetailsAnalyst Forecast
The average price target for Novartis AG is $120.25, which is 5.19% higher than the current price. The consensus rating is "Hold".
| Price Target | $120.25 |
| Price Target Difference | 5.19% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 3.12% |
| EPS Growth Forecast (5Y) | 5.70% |
Stock ForecastsStock Splits
The last stock split was on May 11, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | May 11, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Novartis AG has an Altman Z-Score of 3.88 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.88 |
| Piotroski F-Score | 5 |